Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Edison Investment Research

ZeitAktuelle Nachrichten RatingLeser
12.02.Custodian Property Income REIT - On track to meet dividend target228Custodian Property Income REIT (CREI) has released a trading update for the three months to 31 December 2023 (Q424). The quarterly DPS was fully covered by unaudited EPRA earnings and was in line with...
► Artikel lesen
12.02.Avon Protection - Unmasking its growth potential228Avon Protection's capital markets day highlighted its continued focus on medium-term margin expansion (targeting operating margin of 14-16%), concentrating on its core business of respirators and head...
► Artikel lesen
12.02.GCP Infrastructure Investments - Key takeaways from capital markets day242GCP Infrastructure Investments (GCP) has a mature, diverse and operational portfolio of 51 UK infrastructure assets with a total asset value of £1.1bn and a net asset value (NAV) of £953m, two-thirds...
► Artikel lesen
12.02.Claranova - Guiding to strong H124 EBITDA growth371Claranova reported a small increase in H124 revenue on a constant currency (cc) basis, as good growth in Avanquest and myDevices offset lower revenue in the larger PlanetArt division. Management expects...
► Artikel lesen
12.02.IRLAB Therapeutics - Timeline refresh with numerous inflection points241IRLAB has reported FY23 results and provided operational and regulatory updates, including an end-of-Phase II (EoP2) meeting with the FDA for mesdopetam and extended patent protection for pirepemat...
► Artikel lesen
12.02.Immix Biopharma - Updates galore: NXC-201 ODD (EU) and raise242Immix Biopharma has released back-to-back updates, including EU orphan drug designation (ODD) for its lead CAR-T asset NXC-201, addressing amyloid light chain amyloidosis (ALA), and pricing of its $15m...
► Artikel lesen
09.02.Cordel Group - Railtech play with scalable potential253Cordel Group is a UK technology company that provides an end-to-end data management platform for automated rail infrastructure monitoring. At its core, the company transforms fragmented legacy datasets...
► Artikel lesen
08.02.Creo Medical - Solid FY23 lays the groundwork for 2024236Creo Medical has released a trading update for FY23, an active year for the company, with progress made across all business segments. Traction improved in H223, following Speedboat Inject's European...
► Artikel lesen
08.02.Babcock International Group - Steadfast defence330Babcock's capital markets day reaffirmed its transformation over the past two years, facilitated by a series of disposals and a focus on core defence expertise (69% of H124 revenue). It is well positioned...
► Artikel lesen
08.02.Nanoco - Steps on the pathway to volume production161Nanoco's trading update confirms that H124 revenues and EBITDA are anticipated to be in line with company expectations. The main new information is that the company has commenced the build and fitout...
► Artikel lesen
08.02.Intralot Integrated Lottery Systems and Services - In it to win it227Intralot Integrated Lottery Systems and Services (Intralot) is a leading developer and supplier of integrated gaming systems and services that cover the entire value chain of select gaming markets....
► Artikel lesen
08.02.VolitionRx - Snaring sepsis, with early NETs detection374VolitionRx continues to make headway in growing a body of clinical evidence to build Nu.Q® NETs as a potential breakthrough tool in sepsis. These efforts, coupled with its CE mark in Europe, are a strong...
► Artikel lesen
08.02.AFT Pharmaceuticals - US maiden voyage with Maxigesic IV launch201AFT Pharmaceuticals has announced the launch of Maxigesic IV, an intravenous form of its flagship pain relief prescription medicine, in the US market by licensing partner Hikma, under the brand name...
► Artikel lesen
07.02.discoverIE Group - Orders return to growth; FY24 earnings on track205discoverIE's Q324 trading update confirmed a return to organic order growth, while the decline in organic revenue reflected the expected unwind of customer inventory. The company notes that margins...
► Artikel lesen
07.02.Immix Biopharma - Increased legroom following common-only raise229Immix Biopharma has announced a $15m (gross), fully underwritten equity issue. The company will use the proceeds to fund clinical trials for lead CAR-T asset NXC-201, as well as to meet working capital...
► Artikel lesen
06.02.Secure Trust Bank - FY23 underlying PBT broadly maintained192Secure Trust Bank's (STB's) Q423 trading update showcased a robust performance with net loans of £3.3bn, up 13.6% y-o-y. The bank reaffirmed that it is on track to deliver £5m in annualised cost savings...
► Artikel lesen
06.02.Target Healthcare REIT - Rent cover at a high and fully covered DPS202Target Healthcare REIT's Q224 update shows indexed rent reviews driving increased earnings and property values. Tenant profitability continues to strengthen, reflected in a new high level of rent cover...
► Artikel lesen
06.02.Filtronic - Backlog supports strong growth from H224174Filtronic's recent investment and focus on high-performance radio frequency (RF) design and manufacturing is starting to pay off, with recent new customer wins, development contracts and volume production...
► Artikel lesen
06.02.Ultimovacs - FDA Fast Track boosts confidence in UV1268Ultimovacs has received FDA Fast Track designation for its lead cancer vaccine, UV1, as a potential treatment for mesothelioma and builds on the Orphan Drug designation (ODD) already received in this...
► Artikel lesen
05.02.Information Services Corporation - Services division set to be a key organic driver294In FY23 Information Services Corporation (ISC) remained on a positive trajectory of securing new contracts and customers, despite prevailing macroeconomic headwinds and a subdued Canadian property market....
► Artikel lesen
05.02.Oxford Cannabinoid Technologies - Early signs of revival in clinical activity226Oxford Cannabinoid Technologies (OCT) has announced its H124 results (to end-October 2023), an eventful period for the company, marked by successful clinical progression of lead asset OCT461201, albeit...
► Artikel lesen
05.02.MotorK - Enterprise adoption drives growth197MotorK closed FY23 with annual recurring revenue (ARR) of €34.1m, a 39% increase from the prior year. While both the Retail and Enterprise segments grew over the year, Enterprise ARR more than doubled...
► Artikel lesen
05.02.HgT - Preliminary FY23 NAV TR at 10.7%110HgT's preliminary unaudited FY23 trading update reported a 10.7% net asset value total return (NAV TR) in FY23 (of which c 1% in Q423). This was supported by continued strong trading across its portfolio...
► Artikel lesen
05.02.Gresham House Energy Storage Fund - Responding to challenging times211Gresham House Energy Storage Fund (GRID) is the largest UK fund investing in utility-scale battery energy storage systems (BESS). A recent sharp decline in gas prices, a 'disappointing' start to the...
► Artikel lesen
05.02.EML Payments - Major source of losses stemmed217As part of its strategy to focus on profitable, cash-generative businesses, the boards of EML Payments and PFS Card Services Ireland Limited (PCSIL) have decided to wind down the PCSIL business. This...
► Artikel lesen